For Centene's Medicare Advantage offerings, should we prioritize adding more supplemental benefits or focus on reducing out-of-pocket costs for members?

Introduction

For Centene's Medicare Advantage offerings, we're facing a critical trade-off between adding more supplemental benefits or focusing on reducing out-of-pocket costs for members. This decision will significantly impact our market position, member satisfaction, and financial performance. I'll analyze this trade-off by examining the product context, stakeholder impacts, key metrics, and potential outcomes to provide a strategic recommendation.

Step 1

Clarifying Questions (3 minutes)

• Based on recent market trends, I'm thinking supplemental benefits might be a key differentiator. Could you share how our current supplemental benefits compare to our main competitors?

Why it matters: Helps assess our competitive position and potential for differentiation Expected answer: We're slightly behind in certain popular benefits like dental and vision Impact on approach: Would prioritize adding competitive supplemental benefits

• Considering our member demographics, I'm assuming a significant portion are price-sensitive. What's the breakdown of our membership by income level or subsidy eligibility?

Why it matters: Informs the potential impact of out-of-pocket cost reductions Expected answer: Majority of members are low to middle income, with about 40% receiving subsidies Impact on approach: Would lean towards out-of-pocket cost reductions if confirmed

• Looking at our current star ratings, I'm wondering if either option could significantly impact our quality scores. How are our current CAHPS and HOS scores trending?

Why it matters: Star ratings directly affect our reimbursements and market perception Expected answer: CAHPS scores are below average, particularly in cost-related measures Impact on approach: Would prioritize actions that could improve CAHPS scores

• Considering implementation timelines, I'm curious about our operational readiness. What's our current capacity to roll out new benefits or adjust our cost structure?

Why it matters: Affects feasibility and speed of implementation for either option Expected answer: New benefits take 6-9 months to implement, cost structure changes can be faster Impact on approach: Might favor cost reductions if we need quicker impact

• Given the regulatory environment, I'm thinking about potential compliance risks. Are there any upcoming regulatory changes that could impact either option?

Why it matters: Ensures our strategy aligns with regulatory requirements Expected answer: New CMS rules expanding allowable supplemental benefits are expected Impact on approach: Could make supplemental benefits more attractive if confirmed